PRESCRIPTION FOR A SUCCESSFUL HEALTH CARE ACQUISITIONThe Affordable Care Act has encouraged substantial consolidation within the health care industry, causing a frenzy of acquisitions. This is prevalent among private equity sponsors due to tremendous inefficiencies and opportunities for exponential growth and high returns.

To keep a pulse on this trend, Private Equity Fund investors may want to consider the following factors of health care acquisitions.

HOT: Health care technology and vendors not directly impacted by reduced reimbursement rates, but benefitting from providers/customers servicing more insured people.

HOT: Hospitals, physician practices (especially anesthesia) and outpatient services that can control or reduce health care costs.

NOT: Home health and other sectors dramatically impacted by reimbursement reductions and increased regulation.

Plus reviewing the target’s current billing/claims practices. How will the shift from the traditional “fee for service” model to one that involves risk sharing by providers impact the target’s EBITDA?

Financial relationships between the target and its referral sources should be closely examined under Stark and anti-kickback laws to ensure compliance.

How will state corporate practice of medicine laws impact the transaction structure?

Validating fair market value, commercial reasonableness of the transaction and the target’s relationships with referral sources are increasingly invaluable best practices in health care compliance and ways to better assure future cash flow and return on investment.

www.dlapiper.com

Published by DLA Piper LLP (US) Copyright © 2013 DLA Piper LLP (US) All Rights Reserved.

This bulletin is intended as a general overview and discussion of the subjects dealt with. It is not intended, and should not be used, as a substitute for taking legal advice in any specific situation. DLA Piper will accept no responsibility for any actions taken or not taken on the basis of this publication. Pursuant to applicable Rules of Professional Conduct, it may constitute advertising.

Circular 230 Notice: In compliance with US Treasury Regulations, please be advised that any tax advice given herein (or in any attachment) was not intended or written to be used, and cannot be used, for the purpose of (i) avoiding tax penalties or (ii) promoting, marketing or recommending to another person any transaction or matter addressed herein.

You are receiving this communication because you are a valued client or friend of DLA Piper.

DLA Piper LLP (US) is part of DLA Piper, a global law firm, operating through various separate and distinct legal entities. Further details of these entities can be found at www.dlapiper.com. All rights reserved.

To unsubscribe from this mailing list, reply to this message with REMOVE in the subject line.

DLA Piper LLP (US) | MRS0000003160

For more information about these breaking developments please contact Joshua Kaye at joshua.kaye@dlapiper.com in our Health Care sector.

1. What’s hot and what’s not

2. Forecasting reimbursement changes

3. Vetting financial relationships

4. Impact of state practice

5. Validating fair market value

TAKE 5 AND CALL US IN THE mORNINg